Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer
NCT06863857
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Renal Cancer
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna